View in EDS HTML Full Text PDF Full Text

Combining 1,4-dihydroxy quininib with Bevacizumab/FOLFOX alters angiogenic and inflammatory secretions in ex vivo colorectal tumors.

Saved in:
Bibliographic Details
Title: Combining 1,4-dihydroxy quininib with Bevacizumab/FOLFOX alters angiogenic and inflammatory secretions in ex vivo colorectal tumors.
Authors: Kennedy, Susan A.1 (AUTHOR), Morrissey, Maria E.1 (AUTHOR), Dunne, Margaret R.1 (AUTHOR), O'Connell, Fiona1 (AUTHOR), Butler, Clare T.2 (AUTHOR), Cathcart, Mary-Clare1 (AUTHOR), Buckley, Amy M.1 (AUTHOR), Mehigan, Brian J.3 (AUTHOR), Larkin, John O.3 (AUTHOR), McCormick, Paul3 (AUTHOR), Kennedy, Breandán N.2 (AUTHOR), O'Sullivan, Jacintha1 (AUTHOR) osullij4@tcd.ie
Source: BMC Cancer. 10/2/2020, Vol. 20 Issue 1, p1-14. 14p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14712407
DOI:10.1186/s12885-020-07430-y